U.S. flag

An official website of the United States government

NM_000088.4(COL1A1):c.1004G>A (p.Gly335Asp) AND Osteogenesis imperfecta, perinatal lethal

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Oct 17, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001263481.1

Allele description [Variation Report for NM_000088.4(COL1A1):c.1004G>A (p.Gly335Asp)]

NM_000088.4(COL1A1):c.1004G>A (p.Gly335Asp)

Gene:
COL1A1:collagen type I alpha 1 chain [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.33
Genomic location:
Preferred name:
NM_000088.4(COL1A1):c.1004G>A (p.Gly335Asp)
HGVS:
  • NC_000017.11:g.50195975C>T
  • NG_007400.1:g.10665G>A
  • NM_000088.4:c.1004G>AMANE SELECT
  • NP_000079.2:p.Gly335Asp
  • LRG_1t1:c.1004G>A
  • LRG_1:g.10665G>A
  • NC_000017.10:g.48273336C>T
  • NM_000088.3:c.1004G>A
Protein change:
G335D
Links:
dbSNP: rs1907549643
NCBI 1000 Genomes Browser:
rs1907549643
Molecular consequence:
  • NM_000088.4:c.1004G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Osteogenesis imperfecta, perinatal lethal (OI2)
Synonyms:
OI, TYPE II; Osteogenesis imperfecta congenita perinatal lethal form; Osteogenesis imperfecta congenita; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0008147; MedGen: C0268358; OMIM: 166210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001441563Johns Hopkins Genomics, Johns Hopkins University
criteria provided, single submitter

(ACMG Guidelines, 2015)
Likely pathogenic
(Oct 17, 2020)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

COL1A1/2 Osteogenesis Imperfecta.

Steiner RD, Basel D.

2005 Jan 28 [updated 2024 Mar 14]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(®) [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2024.

PubMed [citation]
PMID:
20301472

Recurrence of perinatal lethal osteogenesis imperfecta in sibships: parsing the risk between parental mosaicism for dominant mutations and autosomal recessive inheritance.

Pyott SM, Pepin MG, Schwarze U, Yang K, Smith G, Byers PH.

Genet Med. 2011 Feb;13(2):125-30. doi: 10.1097/GIM.0b013e318202e0f6.

PubMed [citation]
PMID:
21239989
See all PubMed Citations (4)

Details of each submission

From Johns Hopkins Genomics, Johns Hopkins University, SCV001441563.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

This COL1A1 variant is absent in a large population dataset and has not been reported previously in the literature to our knowledge. This variant was detected in the paternal sample used for analysis. The reduced alternate allele fraction and absence of COL1A1-associated phenotypes suggest c.1004G>A is mosaic in the patient father (see Notes for more information). Three bioinformatics tools predict this variant would be damaging. This variant disrupts a strongly conserved glycine residue in the canonical G-X-Y repeats of the triple helix domain, which are required for stability and structure of the protein. Missense variants in nearby glycine residues have been reported in individuals with osteogenesis imperfecta supporting their functional significance. This variant is not predicted to affect normal exon 16 splicing, although this has not been confirmed experimentally to our knowledge. We consider c.1004G>A to be likely pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 1, 2024